Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer

Clinical trial NCT00744497 · COMPLETED

Trial details

NCT number: NCT00744497
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2008-10-01
Primary completion: 2012-08-01
Enrollment: 1930

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.